Bronchitis
Drug research and approvals for bronchitis: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 19, 2026, 128 studies of bronchitis are recruiting on ClinicalTrials.gov, Health Canada has authorized 0 drug trials for it since 2013, FDA has 0 approved and 1 open orphan designations naming it, and the EU has 1 authorised medicine for it.
- Recruiting worldwide: 128
- Trials authorized in Canada: 0
- FDA orphan approvals: 0
- EU medicines: 1
- Optimising Antibiotic Use for Paediatric Lower Respiratory Tract Infections in AfricaNCT07841691 · Not applicable · University of Witwatersrand, South Africa · starts May 27, 2026
- Effect of AI-Assisted Discharge Education on Parents of Children With Bronchitis/BronchiolitisNCT07774494 · Not applicable · Osmaniye Korkut Ata University · starts Oct 15, 2026
- A Study to Investigate the Efficacy and Safety of Belumosudil Compared With Best Available Therapy in Participants Aged…NCT07771439 · Phase 3 · Sanofi · starts Oct 12, 2026
- Efficacy of an Anti-TSLP Monoclonal Antibody in the Management of Chronic Bronchial Disease Induced by Bronchiolitis…NCT07771855 · Phase 2 · Hopital Foch · starts Jun 24, 2026
- A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease…NCT07759245 · Phase 2 · Eli Lilly and Company · starts Aug 7, 2026
- Mindfulness Intervention to Reduce Patient Reported Symptoms in Patients With Chronic Graft-Versus-Host DiseaseNCT07733141 · Not applicable · City of Hope Medical Center · starts Mar 1, 2027
- A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With…NCT07725939 · Phase 2 · UCB Biopharma SRL · starts Jul 27, 2026
- To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of TreatmentNCT07684820 · Phase 2 · Expedition Therapeutics, Inc · starts Jun 30, 2026
- Dry Dynamic Cupping vs Instrument-Assisted Soft Tissue Mobilization for Chronic Myofascial Low Back PainNCT07685340 · Not applicable · Ibadat International University, Islamabad · starts Jan 1, 2026
Approved 3
- TerbutalineBeta-2 adrenergic receptor agonist
- MentholTransient receptor potential cation channel subfamily M member 8 opener
- CefiximeBacterial penicillin-binding protein inhibitor
Phase 3 7
- ArformoterolBeta-2 adrenergic receptor agonist
- FormoterolBeta-2 adrenergic receptor agonist
- Clavulanic acidBacterial beta-lactamase TEM inhibitor
- AmoxicillinBacterial penicillin-binding protein inhibitor
- AzithromycinBacterial 70S ribosome inhibitor
- ColistinCell outer membrane inhibitor
- LevofloxacinDNA gyrase inhibitor
Phase 2 4
- OmalizumabIg epsilon chain C region inhibitor
- ReslizumabInterleukin-5 inhibitor
- SirolimusFK506-binding protein 1A inhibitor
- AlteplaseTissue-type plasminogen activator exogenous protein
How its trials ended
273 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrongOf the 57 whose ending is known, 39% met their primary endpoint, 14% missed it and 47% stopped early.
- Completed, result not reported13349%
- Status unknown4918%
- Ongoing3412%
- Met its primary endpoint228%
- Stopped: other or unclear207%
- Missed its primary endpoint83%
- Stopped: enrollment or feasibility31%
- Stopped: lack of efficacy21%
- Stopped: safety1<1%
- Stopped: sponsor or business decision1<1%
| Date | Drug | Sponsor | Status |
|---|---|---|---|
| Oct 20, 2014 | AlteplaseTreatment of plastic bronchitis | Kathleen A Stringer, PharmD, FCCP - Professor | Designated |
| Authorised | Medicine | Holder | EPAR |
|---|---|---|---|
| Jul 5, 2010 | DaxasRoflumilast | AstraZeneca AB | EMA ↗ |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA